147 related articles for article (PubMed ID: 10090435)
1. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
3. Improvements in health-related quality of life with sumatriptan treatment for migraine.
Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
[TBL] [Abstract][Full Text] [Related]
4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
6. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
8. Cost savings in migraine associated with less chest pain on new triptan therapy.
Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of sumatriptan in a managed care population.
Legg RF; Sclar DA; Nemec NL; Tarnai J; Mackowiak JI
Am J Manag Care; 1997 Jan; 3(1):117-22. PubMed ID: 10169243
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
11. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
Mayo KW; Osterhaus JT
Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
[TBL] [Abstract][Full Text] [Related]
12. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
13. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
14. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.
Láinez MJ; López A; Pascual AM
Headache; 2005; 45(7):883-90. PubMed ID: 15985105
[TBL] [Abstract][Full Text] [Related]
15. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications.
Luciani RJ; Osterhaus JT; Gutterman DL
J Fam Pract; 1995 Aug; 41(2):147-52. PubMed ID: 7636454
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
19. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
20. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.
Lofland JH; Johnson NE; Batenhorst AS; Nash DB
Arch Intern Med; 1999 Apr; 159(8):857-63. PubMed ID: 10219932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
